Attention deficit hyperactivity disorder (ADHD) is the most common disability diagnosis in children globally. It's estimated ...
A new study suggests the connection between Attention-Deficit/Hyperactivity Disorder (ADHD) and the body’s primary stress ...
Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded ...
Pfizer (PFE) stock is in focus as the firm joins Tris Pharma to settle a lawsuit over supplying an adulterated ADHD drug to ...
Pfizer Inc. and Tris Pharma Inc. will pay the state of Texas $41.5 million to settle claims that it allegedly provided ...
Attention deficit hyperactivity disorder (ADHD) is the most common disability diagnosis in children globally. It's estimated to affect around 8% ...
Powerful psychotropic drugs are often the next step, even though their combined effects in young children haven’t been ...
Maternal acetaminophen use during pregnancy is not clearly linked with autism or attention-deficit/hyperactivity disorder in offspring.
Free Malaysia Today on MSN
Pfizer, Tris Pharma settle for US$41.5mil in Texas ADHD drug case
The settlement ends a 2023 lawsuit alleging pharmaceutical companies manipulated ADHD medication quality tests.
In October, Pharmac announced its decision to fund the Sandoz XR brand of methylphenidate. In December 2024, it began funding lisdexamfetamine to improve supply and provide more options for ADHD ...
In two newly published studies, researchers at the Department of Ethology, Eötvös Loránd University (Hungary) investigated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback